336 related articles for article (PubMed ID: 35996192)
1. Clinical adoption patterns of 0.35 Tesla MR-guided radiation therapy in Europe and Asia.
Slotman BJ; Clark MA; Özyar E; Kim M; Itami J; Tallet A; Debus J; Pfeffer R; Gentile P; Hama Y; Andratschke N; Riou O; Camilleri P; Belka C; Quivrin M; Kim B; Pedersen A; van Overeem Felter M; Kim YI; Kim JH; Fuss M; Valentini V
Radiat Oncol; 2022 Aug; 17(1):146. PubMed ID: 35996192
[TBL] [Abstract][Full Text] [Related]
2. Patterns of utilization and clinical adoption of 0.35 Tesla MR-guided radiation therapy in the United States - Understanding the transition to adaptive, ultra-hypofractionated treatments.
Chuong MD; Clark MA; Henke LE; Kishan AU; Portelance L; Parikh PJ; Bassetti MF; Nagar H; Rosenberg SA; Mehta MP; Refaat T; Rineer JM; Smith A; Seung S; Zaki BI; Fuss M; Mak RH
Clin Transl Radiat Oncol; 2023 Jan; 38():161-168. PubMed ID: 36466748
[TBL] [Abstract][Full Text] [Related]
3. First 500 Fractions Delivered with a Magnetic Resonance-guided Radiotherapy System: Initial Experience.
Sahin B; Zoto Mustafayev T; Gungor G; Aydin G; Yapici B; Atalar B; Ozyar E
Cureus; 2019 Dec; 11(12):e6457. PubMed ID: 32025388
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic Magnetic Resonance-Guided Adaptive and Non-Adaptive Radiotherapy on Combination MR-Linear Accelerators: Current Practice and Future Directions.
Bryant JM; Weygand J; Keit E; Cruz-Chamorro R; Sandoval ML; Oraiqat IM; Andreozzi J; Redler G; Latifi K; Feygelman V; Rosenberg SA
Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046741
[TBL] [Abstract][Full Text] [Related]
5. Clinical application of a sub-fractionation workflow for intrafraction re-planning during prostate radiotherapy treatment on a 1.5 Tesla MR-Linac: A practical method to mitigate intrafraction motion.
Willigenburg T; Zachiu C; Bol GH; de Groot-van Beugel EN; Lagendijk JJW; van der Voort van Zyp JRN; Raaymakers BW; de Boer JCJ
Radiother Oncol; 2022 Nov; 176():25-30. PubMed ID: 36113777
[TBL] [Abstract][Full Text] [Related]
6. MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial.
Hoegen P; Zhang KS; Tonndorf-Martini E; Weykamp F; Regnery S; Naumann P; Lang K; Ristau J; Körber SA; Dreher C; Buchele C; Rippke C; Renkamp CK; Paul KM; König L; Büsch C; Krisam J; Sedlaczek O; Schlemmer HP; Niyazi M; Corradini S; Debus J; Klüter S; Hörner-Rieber J
Radiat Oncol; 2022 Mar; 17(1):59. PubMed ID: 35346270
[TBL] [Abstract][Full Text] [Related]
7. Operating procedures, risk management and challenges during implementation of adaptive and non-adaptive MR-guided radiotherapy: 1-year single-center experience.
Garcia Schüler HI; Pavic M; Mayinger M; Weitkamp N; Chamberlain M; Reiner C; Linsenmeier C; Balermpas P; Krayenbühl J; Guckenberger M; Baumgartl M; Wilke L; Tanadini-Lang S; Andratschke N
Radiat Oncol; 2021 Nov; 16(1):217. PubMed ID: 34775998
[TBL] [Abstract][Full Text] [Related]
8. Retrospective study comparing MR-guided radiation therapy (MRgRT) setup strategies for prostate treatment: repositioning vs. replanning.
Kim JI; Park JM; Choi CH; An HJ; Kim YJ; Kim JH
Radiat Oncol; 2019 Aug; 14(1):139. PubMed ID: 31387593
[TBL] [Abstract][Full Text] [Related]
9. Characterization and longitudinal assessment of daily quality assurance for an MR-guided radiotherapy (MRgRT) linac.
Mittauer KE; Dunkerley DAP; Yadav P; Bayouth JE
J Appl Clin Med Phys; 2019 Nov; 20(11):27-36. PubMed ID: 31633882
[TBL] [Abstract][Full Text] [Related]
10. Intrafraction organ movement in adaptive MR-guided radiotherapy of abdominal lesions - dosimetric impact and how to detect its extent in advance.
Buchele C; Renkamp CK; Regnery S; Behnisch R; Rippke C; Schlüter F; Hoegen-Saßmannshausen P; Debus J; Hörner-Rieber J; Alber M; Klüter S
Radiat Oncol; 2024 Jun; 19(1):80. PubMed ID: 38918828
[TBL] [Abstract][Full Text] [Related]
11. Intrafraction Motion Management With MR-Guided Radiation Therapy.
Fast MF; Cao M; Parikh P; Sonke JJ
Semin Radiat Oncol; 2024 Jan; 34(1):92-106. PubMed ID: 38105098
[TBL] [Abstract][Full Text] [Related]
12. Daily dosimetric variation between image-guided volumetric modulated arc radiotherapy and MR-guided daily adaptive radiotherapy for prostate cancer stereotactic body radiotherapy.
Nicosia L; Sicignano G; Rigo M; Figlia V; Cuccia F; De Simone A; Giaj-Levra N; Mazzola R; Naccarato S; Ricchetti F; Vitale C; Ruggieri R; Alongi F
Acta Oncol; 2021 Feb; 60(2):215-221. PubMed ID: 32945701
[TBL] [Abstract][Full Text] [Related]
13. Role of On-Table Plan Adaptation in MR-Guided Ablative Radiation Therapy for Central Lung Tumors.
Finazzi T; Palacios MA; Spoelstra FOB; Haasbeek CJA; Bruynzeel AME; Slotman BJ; Lagerwaard FJ; Senan S
Int J Radiat Oncol Biol Phys; 2019 Jul; 104(4):933-941. PubMed ID: 30928360
[TBL] [Abstract][Full Text] [Related]
14. A comparative planning study for lung SABR between tri-Co-60 magnetic resonance image guided radiation therapy system and volumetric modulated arc therapy.
Park JM; Park SY; Kim HJ; Wu HG; Carlson J; Kim JI
Radiother Oncol; 2016 Aug; 120(2):279-85. PubMed ID: 27401404
[TBL] [Abstract][Full Text] [Related]
15. Triggered kV Imaging During Spine SBRT for Intrafraction Motion Management.
Koo J; Nardella L; Degnan M; Andreozzi J; Yu HM; Penagaricano J; Johnstone PAS; Oliver D; Ahmed K; Rosenberg SA; Wuthrick E; Diaz R; Feygelman V; Latifi K; Moros EG; Redler G
Technol Cancer Res Treat; 2021; 20():15330338211063033. PubMed ID: 34855577
[No Abstract] [Full Text] [Related]
16. Seminal vesicle intrafraction motion during the delivery of radiotherapy sessions on a 1.5 T MR-Linac.
Muinck Keizer DM; Willigenburg T; der Voort van Zyp JRN; Raaymakers BW; Lagendijk JJW; Boer JCJ
Radiother Oncol; 2021 Sep; 162():162-169. PubMed ID: 34293410
[TBL] [Abstract][Full Text] [Related]
17. Retrospective evaluation of decision-making for pancreatic stereotactic MR-guided adaptive radiotherapy.
Tyran M; Jiang N; Cao M; Raldow A; Lamb JM; Low D; Luterstein E; Steinberg ML; Lee P
Radiother Oncol; 2018 Nov; 129(2):319-325. PubMed ID: 30174107
[TBL] [Abstract][Full Text] [Related]
18. Initial clinical experience with magnetic resonance-guided radiotherapy in pediatric patients: Lessons learned from a single institution with proton therapy.
Hall MD; Mittauer KE; Herrera R; Von Werne K; Kotecha R; Kalman NS; McCulloch J; Alvarez D; McAllister NC; Doty DG; Rzepczynski AE; Deere W; Gutierrez AN; Chuong MD
Front Oncol; 2022; 12():1037674. PubMed ID: 36713501
[TBL] [Abstract][Full Text] [Related]
19. Clinical application of MR-Linac in tumor radiotherapy: a systematic review.
Liu X; Li Z; Yin Y
Radiat Oncol; 2023 Mar; 18(1):52. PubMed ID: 36918884
[TBL] [Abstract][Full Text] [Related]
20. MRI-guided Radiotherapy (MRgRT) for Treatment of Oligometastases: Review of Clinical Applications and Challenges.
Chetty IJ; Doemer AJ; Dolan JL; Kim JP; Cunningham JM; Dragovic J; Feldman A; Walker EM; Elshaikh M; Adil K; Movsas B; Parikh PJ
Int J Radiat Oncol Biol Phys; 2022 Dec; 114(5):950-967. PubMed ID: 35901978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
